Figure 5.Serum levels of fluorescent hydroxynonenal- (HNE, A) and malondialdehyde- (MDA, B) protein adducts in patients treated with calcineurin inhibitor (CNi) or CNi + mTOR inhibitor (CNi+mTORi). AUF, arbitrary units of fluorescence.
Figure 5 — mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction | Aging
